MAPT and Alzheimer disease: Recently, Malpetti et al. revealed the strong correlation between tau pathology and neuroinflammation by using positron emission tomography (PET) imaging, indicating that the patterns of tau burden in posterior cortical regions and microglial activation in the anterior temporal lobes could predict cognitive declines in AD patients [119].